Tocilizumab for COVID-19: a real 'miracle drug'?

被引:1
|
作者
Nasim, Sundus [1 ]
Hashmi, Shariq Haider [2 ]
Azim, Dua [1 ]
Kumar, Sohail [1 ]
Nasim, Jasia [1 ]
机构
[1] Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan
[2] NYU, Grossman Sch Med, New York, NY USA
关键词
D O I
10.1080/23744235.2020.1780307
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:681 / 682
页数:2
相关论文
共 50 条
  • [41] Tocilizumab in the Management of COVID-19: A Preliminary Report
    Li, Michael
    Yoo, Erika J.
    Baram, Michael
    McArthur, Melanie
    Skeehan, Connor
    Awsare, Bharat
    George, Gautam
    Summer, Ross
    Zurlo, John
    Jallo, Jack
    Roman, Jesse
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 361 (02): : 208 - 215
  • [42] Modulation of Covid-19 cytokine storm by tocilizumab
    Boretti, Alberto
    Banik, Bimal
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 823 - 828
  • [43] Tocilizumab and COVID-19: Timing of administration assessment
    Richier, Q.
    Jachiet, V
    Bonnemains, V
    Placais, L.
    Abisror, N.
    Garnier, M.
    Pacanowski, J.
    Dhote, R.
    Hinchschberger, O.
    Michel, M.
    Bienvenu, B.
    Comarmond, C.
    Lacombe, K.
    Mekinian, A.
    INFECTIOUS DISEASES NOW, 2022, 52 (01): : 31 - 34
  • [44] Tocilizumab administration in a refractory case of COVID-19
    Dastan, Farzaneh
    Nadji, Seyed Alireza
    Saffaei, Ali
    Tabarsi, Payam
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (02)
  • [45] Feasibility of tocilizumab in ICU patients with COVID-19
    Issa, Nahema
    Dumery, Margot
    Guisset, Olivier
    Mourissoux, Gaelle
    Bonnet, Fabrice
    Camou, Fabrice
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 46 - 47
  • [46] Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
    Stone, John H.
    Frigault, Matthew J.
    Serling-Boyd, Naomi J.
    Fernandes, Ana D.
    Harvey, Liam
    Foulkes, Andrea S.
    Horick, Nora K.
    Healy, Brian C.
    Shah, Ruta
    Bensaci, Ana Maria
    Woolley, Ann E.
    Nikiforow, Sarah
    Lin, Nina
    Sagar, Manish
    Schrager, Harry
    Huckins, David S.
    Axelrod, Matthew
    Pincus, Michael D.
    Fleisher, Jorge
    Sacks, Chana A.
    Dougan, Michael
    North, Crystal M.
    Halvorsen, Yuan-Di
    Thurber, Tara K.
    Dagher, Zeina
    Scherer, Allison
    Wallwork, Rachel S.
    Kim, Arthur Y.
    Schoenfeld, Sara
    Sen, Pritha
    Neilan, Tomas G.
    Perugino, Cory A.
    Unizony, Sebastian H.
    Collier, Deborah S.
    Matza, Mark A.
    Yinh, Janeth M.
    Bowman, Kathryn A.
    Meyerowitz, Eric
    Zafar, Amna
    Drobni, Zsofia D.
    Bolster, Marcy B.
    Kohler, Minna
    D'Silva, Kristin M.
    Dau, Jonathan
    Lockwood, Megan M.
    Cubbison, Caroline
    Weber, Brittany N.
    Mansour, Michael K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (24): : 2333 - 2344
  • [47] Tocilizumab, Adipokines and Severe Complications of COVID-19
    Fioravanti, Antonella
    Porcelli, Brunetta
    Terzuoli, Lucia
    Bacarelli, Maria Romana
    Tenti, Sara
    Cheleschi, Sara
    CLINICAL DRUG INVESTIGATION, 2020, 40 (09) : 891 - 892
  • [48] Candidemia in COVID-19 treated with corticosteroids and tocilizumab
    Yamamoto, Koichiro
    Nakamura, Kaoru
    Hagiya, Hideharu
    Otsuka, Fumio
    CLINICAL CASE REPORTS, 2021, 9 (09):
  • [49] Treatment of the Patient with COVID-19 Pneumonia with Tocilizumab
    Gunal, Ozgur
    Udurgucu, Hatice
    Senbaba, Ayse
    Kilic, Suleyman Sirri
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2020, 25 (02): : 279 - 281
  • [50] Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
    Salama, Carlos
    Han, Jian
    Yau, Linda
    Reiss, William G.
    Kramer, Benjamin
    Neidhart, Jeffrey D.
    Criner, Gerard J.
    Kaplan-Lewis, Emma
    Baden, Rachel
    Pandit, Lavannya
    Cameron, Miriam L.
    Garcia-Diaz, Julia
    Chavez, Victoria
    Mekebeb-Reuter, Martha
    de Menezes, Ferdinando Lima
    Shah, Reena
    Gonzalez-Lara, Maria F.
    Assman, Beverly
    Freedman, Jamie
    Mohan, Shalini, V
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (01): : 20 - 30